Methotrexate treatment of rheumatoid arthritis: is a fortnightly maintenance schedule enough?
AUTOR(ES)
Tishler, M
RESUMO
In 15 patients with rheumatoid arthritis who were in clinical remission the weekly regimen of methotrexate treatment was changed to fortnightly without a change in dose. A total of 13 patients completed a 12 month trial. No change in clinical or laboratory parameters occurred. There was no change in the use of analgesics or non-steroidal anti-inflammatory drugs and the patients remained in remission. Two patients had to be withdrawn after two and four months respectively because of a flare in disease activity. It is suggested that in most patients with rheumatoid arthritis who are treated with methotrexate and whose disease activity is stable a fortnightly regimen can be permitted without affecting drug efficacy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1004930Documentos Relacionados
- Oral methotrexate in the treatment of rheumatoid arthritis: allergic agranulocytosis?
- Rheumatoid Arthritis: The Treatment Controversy
- Maintenance chrysotherapy in rheumatoid arthritis: a comparison of 2 dose schedules.
- Bacterial Identification for Publication: When Is Enough Enough?
- Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations.